Tech Company Financing Transactions
Sensorium Therapeutics Funding Round
Sensorium Therapeutics, based in Boston, scored $25 million from Dolby Family Ventures, Hatteras Venture Partners and Mission BioCapital.
Transaction Overview
Company Name
Announced On
8/19/2025
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series A
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
38 Wareham St Fl 2
Boston, MA 02118
USA
Boston, MA 02118
USA
Phone
Undisclosed
Website
Email Address
Overview
Founded by world-class researchers, clinicians, and thought leaders from Massachusetts General Hospital and Harvard University, Sensorium Therapeutics is biotechnology company leveraging cutting-edge chemistry, neuroscience, and machine learning to develop nature-derived psychoactive medicines for mental health. Inspired by the real-world human benefits of plants and fungi, Sensorium's groundbreaking Biodynamic Discovery Platform leverages cutting-edge chemistry, neuroscience, and machine learning to reproduce, adapt, and enhance targeted molecules to elevate their utility as modern medicines that can deliver transformational benefits to patients around the world.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Richard Simon
Co-Founder
Stephen Haggarty
Co-Founder
Jerrold Rosenbaum
Co-Founder
Alex Simon
Browse more venture capital transactions:
Prev: 8/19/2025: Yourway Learning venture capital transaction
Next: 8/19/2025: ShiftUp venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to report on all VC transactions involving tech companies. VC investment data records reported here come from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs